SELECT Trial: The Evidence for CV Coverage The SELECT trial (published in NEJM, November 2023) demonstrated that Wegovy reduces cardiovascular events: [27] 20% reduction in major adverse cardiovascular events (MACE) Includes heart attacks, strokes, and cardiovascular death 17,604 participants followed for ~3.3 years All participants had established cardiovascular disease plus obesity/overweight Typical Plan Coverage Criteria for CV Indication Medicare plans that cover Wegovy for cardiovascular risk reduction typically require: Clinical Criteria Established cardiovascular disease (prior heart attack, stroke, or peripheral artery disease) BMI (body mass index) 27 kg/m No Type 2 diabetes (or T2D not adequately controlled) Concurrent lifestyle modifications (diet and exercise) Required Documentation Cardiology records documenting established CVD Current BMI (height and weight within last 30 days) Letter of Medical Necessity from cardiologist or primary care provider Documentation of lifestyle modification attempts ICD-10 Codes for CV vs
Advanced clinical treatments and aesthetic enhancements designed to revitalize your natural beauty
Moreover, a prospective cohort study including 18,961 subjects reported in the year 2022 that a 5-year increase in the duration of diabetes resulted in an excess risk of approximately 20% for CVD and stroke [9]
One of the top questions we encounter is, "Does insurance cover semaglutide?" The truth is coverage varies by insurer and individual plan
Stay consistent with your training and your creatine supplementation protocol, and you wont need to spend a single second stressing about setbacks, lost progress, or starting your muscle-building journey from scratch
:max_bytes(150000):strip_icc()/Health-GLP1-pill-vs-shot-137cf589ddca421bb0aef5c5d7aec64a.png)
